Kyruus, a US-based producer of software for patient management in hospitals, raised a $25m series C round backed by McKesson Ventures, the corporate venturing arm of pharmaceutical firm McKesson yesterday.
Fidelity Biosciences, an investment subsidiary of financial services conglomerate Fidelity International and health care system Providence Health and Services, as well as Leerink Capital Partners, Venrock, Highland Capital Partners and Lux Capital also supported the round, which was led by New Leaf Venture Partners.
Kyruus uses big data analytics for a patient management software aimed at hospitals, health systems, and surgeries. The platform, dubbed ProviderMatch, facilitates scheduling and referrals of patients to the right specialists.
The funding will go towards expanding the client development and implementation teams, and towards further development of the software.
Kyruus previously closed an $11m series B round in 2013, backed by Fidelity Biosciences, Lux Capital, Venrock and Highland Capital Partners.
Highland Capital, Venrock and Gerson Lehrman Group also took part in an $8.5m series A round in 2011, alongside assorted angel investors.